UMB Financial Q2 revenue rises on loan growth, fee income
UMB Financial Q2 revenue rises on loan growth, fee income
Overview
US financial services firm's Q2 revenue rose 12.9% yr/yr, driven by loan and fee income growth
Adjusted EPS for Q2 increased 21.1% from a year ago
Company raised quarterly dividend by 16.3%
Outlook
Company did not provide specific guidance or outlook for future quarters or full-year results
Result Drivers
LOAN GROWTH - Co said Q2 results were driven by strong organic loan growth, especially in commercial and industrial lending
FEE INCOME AND INVESTMENT GAINS - Higher noninterest income was led by gains on private investment holdings and increased fees from fund services, corporate trust, and brokerage
ASSET QUALITY IMPROVEMENT - Net charge-offs declined and nonperforming loans fell 15.7% from the prior quarter
Company press release: ID:nBw8fVMrHa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 EPS |
| $3.56 |
|
Q2 Net Income |
| $277.57 mln |
|
Q2 Net Interest Income |
| $532.50 mln |
|
Q2 Net Interest Margin (FTE) |
| 3.32% |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the banks peer group is "buy"
Wall Street's median 12-month price target for UMB Financial Corp is $161.00, about 14.2% above its July 27 closing price of $140.97
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 9 three months ago
Reuters Recommended Reads
July 27 - Lakeland Financial Q2 profit rises on loan growth
July 27 - Commercial BancGroup Q2 net income rises, driven by loan growth
July 27 - Bladex Q2 revenue rises on higher commercial balances, record fees
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on UMB Financial
See all newsBrief: UMB Financial Corp - To Redeem All 2.75% Subordinated Notes Due 2031 On Sept 15, 2026 - SEC Filing
U.S. RESEARCH ROUNDUP-Dollar General, Palo Alto, Workday
Lawsuit against Bristol Myers over delayed cancer drug is revived (updated)
Lawsuit against Bristol Myers over delayed cancer drug is revived
UMB Financial Corp reports results for the quarter ended June 30 - Earnings Summary